Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment

Progress in Cardiovascular Diseases
E Kevin Heist, Jeremy N Ruskin

Abstract

Atrial fibrillation (AF) and congestive heart failure (CHF) are commonly encountered together, and either condition predisposes to the other. Risk factors for AF and CHF include age, hypertension, valve disease, and myocardial infarction, as well as a variety of medical conditions and genetic variants. Congestive heart failure and AF share common mechanisms, including myocardial fibrosis and dysregulation of intracellular calcium and neuroendocrine function. Pharmacological treatments including beta-blockers, digoxin, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers can be useful in treating both of these conditions. Antiarrhythmic medications intended to achieve and maintain sinus rhythm may be beneficial in some patients with AF and CHF. Advances in pacemaker and defibrillator therapy, including cardiac resynchronization therapy, may also benefit patients with AF and CHF. Surgical and catheter-based ablation therapy can restore sinus rhythm in patients with AF, with proven benefit in patients with concommitant CHF. Investigational biologic therapy, including cell and gene based therapy, offers promise for the future of reversing the pathophysiological mechanisms that underlie AF and CHF.

References

Mar 16, 1994·JAMA : the Journal of the American Medical Association·E J BenjaminP A Wolf
Mar 1, 1993·Cardiovascular Research·K T WeberJ S Janicki
Sep 3, 1998·The New England Journal of Medicine·M HaïssaguerreJ Clémenty
Nov 4, 2000·Journal of Cardiovascular Electrophysiology·G R D'AllonnesJ C Daubert
Nov 9, 2001·Archives of Internal Medicine·R T TsuyukiS Yusuf
Jan 30, 2002·Circulation·Hideshi NiimuraChristine E Seidman
Dec 6, 2002·The New England Journal of Medicine·D G WyseUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Dec 6, 2002·The New England Journal of Medicine·Isabelle C Van GelderUNKNOWN Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group
Jun 25, 2003·Journal of the American College of Cardiology·Dawood DarbarTimothy M Olson
Sep 3, 2003·Journal of Cardiovascular Electrophysiology·Patrick T Ellinor, Calum A Macrae
Dec 17, 2003·The American Journal of Cardiology·Yinong Young-XuShmuel Ravid
May 20, 2004·Journal of Cardiovascular Electrophysiology·Moussa MansourDavid Keane
Jun 3, 2004·The Annals of Thoracic Surgery·Gustavo Glotz de LimaIvo A Nesralla
Jul 14, 2004·Circulation·Apoor S GamiVirend K Somers
Aug 6, 2004·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Valérie Valls-BertaultJean-Jacques Blanc
Aug 18, 2004·Circulation·Donald M Lloyd-JonesEmelia J Benjamin
Aug 28, 2004·The Medical Clinics of North America·Lars H Lund, Donna Mancini
Sep 1, 2004·International Journal of Cardiology·Ijaz A KhanReshma C Nair
Sep 18, 2004·The American Journal of Cardiology·Sana M Al-KhatibRobert M Califf
Sep 25, 2004·American Heart Journal·Rossella MarcucciDomenico Prisco
Nov 16, 2004·The American Journal of Cardiology·Jeffrey L AndersonUNKNOWN Intermountain Heart Collaborative Study group

❮ Previous
Next ❯

Citations

Sep 24, 2008·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Giovanni B PeregoUNKNOWN Optivol-CRT Clinical Service Observational Group
May 15, 2012·Cardiology in Review·Amir Y ShaikhDavid D McManus
Jul 21, 2010·International Journal of Clinical Practice·M KowalczykJ Rysz
Sep 17, 2011·Circulation. Heart Failure·Alanna M ChamberlainVéronique L Roger
Nov 18, 2009·The International Journal of Neuroscience·John GunstadRonald A Cohen
Nov 26, 2008·Heart Failure Clinics·Peter S Pang, Mihai Gheorghiade
Jul 16, 2008·International Journal of Cardiology·Ana RuigómezLuis Alberto García Rodríguez
Feb 1, 2008·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Feridun KosarIbrahim Sahin
May 22, 2010·Journal of Cardiovascular Electrophysiology·Christian JonsUNKNOWN Cardiac Arrhythmias and Risk Stratification after Acute Myocardial Infarction (CARISMA) Study Group
Apr 27, 2012·TheScientificWorldJournal·Lia MillucciAnnalisa Santucci
Aug 15, 2009·The American Journal of Pathology·Lynette PretoriusJulie R McMullen
Jun 23, 2015·European Journal of Heart Failure·Francesco Grigioni, Michele Senni
Oct 6, 2006·Expert Opinion on Pharmacotherapy·Stéphane Ederhy, Ariel Cohen
Jul 31, 2007·Journal of the American College of Cardiology·Masahiro OgawaPeng-Sheng Chen
Jun 9, 2012·Journal of the American College of Cardiology·Cristina E MolinaRodolphe Fischmeister
Apr 10, 2007·Biochemical and Biophysical Research Communications·Frank Lezoualc'hAntoine Bril
May 18, 2010·Journal of Cardiovascular Pharmacology and Therapeutics·Gabor Z DurayStefan H Hohnloser
Apr 10, 2018·Journal of Cardiovascular Electrophysiology·Nav MalhiMarc W Deyell
Jul 24, 2008·The Journal of Clinical Endocrinology and Metabolism·Karl MichaëlssonHåkan Melhus
Mar 20, 2009·Expert Review of Cardiovascular Therapy·Wanwarang Wongcharoen, Shih-Ann Chen
May 31, 2016·Journal of Cachexia, Sarcopenia and Muscle·Tahnee SenteChristiaan J Vrints
Dec 13, 2019·Circulation. Arrhythmia and Electrophysiology·Dingxin QinEdwin Kevin Heist
May 8, 2021·ESC Heart Failure·Jin Joo ParkDong-Ju Choi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.